Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients - Ruzzo, A; Graziano, F; Galli, F (Br J Cancer, 2017)
et al.